 | • レポートコード：MRC2312MG12246 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の薬用&食品同族健康製品市場規模と予測を収録しています。・世界の薬用&食品同族健康製品市場：売上、2018年-2023年、2024年-2029年 ・世界の薬用&食品同族健康製品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の薬用&食品同族健康製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「口腔美容」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 薬用&食品同族健康製品のグローバル主要企業は、Isabel Healthcare、 Nature's Way、 Beijing Tongrentang Co., Ltd.、 Dong-E-E-Jiao Co., Ltd.、 By-health Co., Ltd.、 Zhejiang Renzhichu Health Industry Co., Ltd.、 Hanguk Insam Gongsa、 Shandong Gubentang Health Industry Development Group Co., Ltd.、 Renhe Pharmacy Co., Ltd.、 Ningxia Qilixiang Medlar Co., Ltd.、 Nu Skin Enterprisesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、薬用&食品同族健康製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の薬用&食品同族健康製品市場：タイプ別、2018年-2023年、2024年-2029年 世界の薬用&食品同族健康製品市場：タイプ別市場シェア、2022年 ・口腔美容、肝臓保護、睡眠補助、その他のタイプ 世界の薬用&食品同族健康製品市場：用途別、2018年-2023年、2024年-2029年 世界の薬用&食品同族健康製品市場：用途別市場シェア、2022年 ・健康維持、栄養補助食品、心臓&脳の健康、関節の健康、その他 世界の薬用&食品同族健康製品市場：地域・国別、2018年-2023年、2024年-2029年 世界の薬用&食品同族健康製品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における薬用&食品同族健康製品のグローバル売上、2018年-2023年 ・主要企業における薬用&食品同族健康製品のグローバル売上シェア、2022年 ・主要企業における薬用&食品同族健康製品のグローバル販売量、2018年-2023年 ・主要企業における薬用&食品同族健康製品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Isabel Healthcare、 Nature's Way、 Beijing Tongrentang Co., Ltd.、 Dong-E-E-Jiao Co., Ltd.、 By-health Co., Ltd.、 Zhejiang Renzhichu Health Industry Co., Ltd.、 Hanguk Insam Gongsa、 Shandong Gubentang Health Industry Development Group Co., Ltd.、 Renhe Pharmacy Co., Ltd.、 Ningxia Qilixiang Medlar Co., Ltd.、 Nu Skin Enterprises ************************************************************* ・調査・分析レポートの概要 薬用&食品同族健康製品市場の定義 市場セグメント 世界の薬用&食品同族健康製品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の薬用&食品同族健康製品市場規模 世界の薬用&食品同族健康製品市場規模：2022年 VS 2029年 世界の薬用&食品同族健康製品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの薬用&食品同族健康製品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の薬用&食品同族健康製品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：口腔美容、肝臓保護、睡眠補助、その他のタイプ 薬用&食品同族健康製品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：健康維持、栄養補助食品、心臓&脳の健康、関節の健康、その他 薬用&食品同族健康製品の用途別グローバル売上・予測 ・地域別市場分析 地域別薬用&食品同族健康製品市場規模 2022年と2029年 地域別薬用&食品同族健康製品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Isabel Healthcare、 Nature's Way、 Beijing Tongrentang Co., Ltd.、 Dong-E-E-Jiao Co., Ltd.、 By-health Co., Ltd.、 Zhejiang Renzhichu Health Industry Co., Ltd.、 Hanguk Insam Gongsa、 Shandong Gubentang Health Industry Development Group Co., Ltd.、 Renhe Pharmacy Co., Ltd.、 Ningxia Qilixiang Medlar Co., Ltd.、 Nu Skin Enterprises ... |
This research report provides a comprehensive analysis of the Medicinal and Food Homologous Health Product market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Medicinal and Food Homologous Health Product market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Medicinal and Food Homologous Health Product, challenges faced by the industry, and potential opportunities for market players.
The global Medicinal and Food Homologous Health Product market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Medicinal and Food Homologous Health Product market presents opportunities for various stakeholders, including Health Maintenance, Nutritional Supplement. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Medicinal and Food Homologous Health Product market. Additionally, the growing consumer demand present avenues for market expansion.
The global Medicinal and Food Homologous Health Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Medicinal and Food Homologous Health Product market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Medicinal and Food Homologous Health Product market.
Market Overview: The report provides a comprehensive overview of the Medicinal and Food Homologous Health Product market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral Beauty, Liver Protection), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Medicinal and Food Homologous Health Product market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Medicinal and Food Homologous Health Product market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Medicinal and Food Homologous Health Product market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Medicinal and Food Homologous Health Product market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Medicinal and Food Homologous Health Product market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Medicinal and Food Homologous Health Product market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Medicinal and Food Homologous Health Product, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Medicinal and Food Homologous Health Product market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Medicinal and Food Homologous Health Product market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Oral Beauty
Liver Protection
Sleep Aid
Other Types
Market segment by Application
Health Maintenance
Nutritional Supplement
Heart and Brain Health
Joint Health
Others
Global Medicinal and Food Homologous Health Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Isabel Healthcare
Nature’s Way
Beijing Tongrentang Co., Ltd.
Dong-E-E-Jiao Co., Ltd.
By-health Co., Ltd.
Zhejiang Renzhichu Health Industry Co., Ltd.
Hanguk Insam Gongsa
Shandong Gubentang Health Industry Development Group Co., Ltd.
Renhe Pharmacy Co., Ltd.
Ningxia Qilixiang Medlar Co., Ltd.
Nu Skin Enterprises
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medicinal and Food Homologous Health Product, market overview.
Chapter 2: Global Medicinal and Food Homologous Health Product market size in revenue and volume.
Chapter 3: Detailed analysis of Medicinal and Food Homologous Health Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medicinal and Food Homologous Health Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medicinal and Food Homologous Health Product capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Medicinal and Food Homologous Health Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medicinal and Food Homologous Health Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medicinal and Food Homologous Health Product Overall Market Size
2.1 Global Medicinal and Food Homologous Health Product Market Size: 2022 VS 2029
2.2 Global Medicinal and Food Homologous Health Product Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medicinal and Food Homologous Health Product Sales: 2018-2029
3 Company Landscape
3.1 Top Medicinal and Food Homologous Health Product Players in Global Market
3.2 Top Global Medicinal and Food Homologous Health Product Companies Ranked by Revenue
3.3 Global Medicinal and Food Homologous Health Product Revenue by Companies
3.4 Global Medicinal and Food Homologous Health Product Sales by Companies
3.5 Global Medicinal and Food Homologous Health Product Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medicinal and Food Homologous Health Product Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medicinal and Food Homologous Health Product Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medicinal and Food Homologous Health Product Players in Global Market
3.8.1 List of Global Tier 1 Medicinal and Food Homologous Health Product Companies
3.8.2 List of Global Tier 2 and Tier 3 Medicinal and Food Homologous Health Product Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medicinal and Food Homologous Health Product Market Size Markets, 2022 & 2029
4.1.2 Oral Beauty
4.1.3 Liver Protection
4.1.4 Sleep Aid
4.1.5 Other Types
4.2 By Type – Global Medicinal and Food Homologous Health Product Revenue & Forecasts
4.2.1 By Type – Global Medicinal and Food Homologous Health Product Revenue, 2018-2023
4.2.2 By Type – Global Medicinal and Food Homologous Health Product Revenue, 2024-2029
4.2.3 By Type – Global Medicinal and Food Homologous Health Product Revenue Market Share, 2018-2029
4.3 By Type – Global Medicinal and Food Homologous Health Product Sales & Forecasts
4.3.1 By Type – Global Medicinal and Food Homologous Health Product Sales, 2018-2023
4.3.2 By Type – Global Medicinal and Food Homologous Health Product Sales, 2024-2029
4.3.3 By Type – Global Medicinal and Food Homologous Health Product Sales Market Share, 2018-2029
4.4 By Type – Global Medicinal and Food Homologous Health Product Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medicinal and Food Homologous Health Product Market Size, 2022 & 2029
5.1.2 Health Maintenance
5.1.3 Nutritional Supplement
5.1.4 Heart and Brain Health
5.1.5 Joint Health
5.1.6 Others
5.2 By Application – Global Medicinal and Food Homologous Health Product Revenue & Forecasts
5.2.1 By Application – Global Medicinal and Food Homologous Health Product Revenue, 2018-2023
5.2.2 By Application – Global Medicinal and Food Homologous Health Product Revenue, 2024-2029
5.2.3 By Application – Global Medicinal and Food Homologous Health Product Revenue Market Share, 2018-2029
5.3 By Application – Global Medicinal and Food Homologous Health Product Sales & Forecasts
5.3.1 By Application – Global Medicinal and Food Homologous Health Product Sales, 2018-2023
5.3.2 By Application – Global Medicinal and Food Homologous Health Product Sales, 2024-2029
5.3.3 By Application – Global Medicinal and Food Homologous Health Product Sales Market Share, 2018-2029
5.4 By Application – Global Medicinal and Food Homologous Health Product Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medicinal and Food Homologous Health Product Market Size, 2022 & 2029
6.2 By Region – Global Medicinal and Food Homologous Health Product Revenue & Forecasts
6.2.1 By Region – Global Medicinal and Food Homologous Health Product Revenue, 2018-2023
6.2.2 By Region – Global Medicinal and Food Homologous Health Product Revenue, 2024-2029
6.2.3 By Region – Global Medicinal and Food Homologous Health Product Revenue Market Share, 2018-2029
6.3 By Region – Global Medicinal and Food Homologous Health Product Sales & Forecasts
6.3.1 By Region – Global Medicinal and Food Homologous Health Product Sales, 2018-2023
6.3.2 By Region – Global Medicinal and Food Homologous Health Product Sales, 2024-2029
6.3.3 By Region – Global Medicinal and Food Homologous Health Product Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medicinal and Food Homologous Health Product Revenue, 2018-2029
6.4.2 By Country – North America Medicinal and Food Homologous Health Product Sales, 2018-2029
6.4.3 US Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.4.4 Canada Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.4.5 Mexico Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medicinal and Food Homologous Health Product Revenue, 2018-2029
6.5.2 By Country – Europe Medicinal and Food Homologous Health Product Sales, 2018-2029
6.5.3 Germany Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.5.4 France Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.5.5 U.K. Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.5.6 Italy Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.5.7 Russia Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.5.8 Nordic Countries Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.5.9 Benelux Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medicinal and Food Homologous Health Product Revenue, 2018-2029
6.6.2 By Region – Asia Medicinal and Food Homologous Health Product Sales, 2018-2029
6.6.3 China Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.6.4 Japan Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.6.5 South Korea Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.6.6 Southeast Asia Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.6.7 India Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medicinal and Food Homologous Health Product Revenue, 2018-2029
6.7.2 By Country – South America Medicinal and Food Homologous Health Product Sales, 2018-2029
6.7.3 Brazil Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.7.4 Argentina Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medicinal and Food Homologous Health Product Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medicinal and Food Homologous Health Product Sales, 2018-2029
6.8.3 Turkey Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.8.4 Israel Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.8.5 Saudi Arabia Medicinal and Food Homologous Health Product Market Size, 2018-2029
6.8.6 UAE Medicinal and Food Homologous Health Product Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Isabel Healthcare
7.1.1 Isabel Healthcare Company Summary
7.1.2 Isabel Healthcare Business Overview
7.1.3 Isabel Healthcare Medicinal and Food Homologous Health Product Major Product Offerings
7.1.4 Isabel Healthcare Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.1.5 Isabel Healthcare Key News & Latest Developments
7.2 Nature’s Way
7.2.1 Nature’s Way Company Summary
7.2.2 Nature’s Way Business Overview
7.2.3 Nature’s Way Medicinal and Food Homologous Health Product Major Product Offerings
7.2.4 Nature’s Way Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.2.5 Nature’s Way Key News & Latest Developments
7.3 Beijing Tongrentang Co., Ltd.
7.3.1 Beijing Tongrentang Co., Ltd. Company Summary
7.3.2 Beijing Tongrentang Co., Ltd. Business Overview
7.3.3 Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Major Product Offerings
7.3.4 Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.3.5 Beijing Tongrentang Co., Ltd. Key News & Latest Developments
7.4 Dong-E-E-Jiao Co., Ltd.
7.4.1 Dong-E-E-Jiao Co., Ltd. Company Summary
7.4.2 Dong-E-E-Jiao Co., Ltd. Business Overview
7.4.3 Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Major Product Offerings
7.4.4 Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.4.5 Dong-E-E-Jiao Co., Ltd. Key News & Latest Developments
7.5 By-health Co., Ltd.
7.5.1 By-health Co., Ltd. Company Summary
7.5.2 By-health Co., Ltd. Business Overview
7.5.3 By-health Co., Ltd. Medicinal and Food Homologous Health Product Major Product Offerings
7.5.4 By-health Co., Ltd. Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.5.5 By-health Co., Ltd. Key News & Latest Developments
7.6 Zhejiang Renzhichu Health Industry Co., Ltd.
7.6.1 Zhejiang Renzhichu Health Industry Co., Ltd. Company Summary
7.6.2 Zhejiang Renzhichu Health Industry Co., Ltd. Business Overview
7.6.3 Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Major Product Offerings
7.6.4 Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.6.5 Zhejiang Renzhichu Health Industry Co., Ltd. Key News & Latest Developments
7.7 Hanguk Insam Gongsa
7.7.1 Hanguk Insam Gongsa Company Summary
7.7.2 Hanguk Insam Gongsa Business Overview
7.7.3 Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Major Product Offerings
7.7.4 Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.7.5 Hanguk Insam Gongsa Key News & Latest Developments
7.8 Shandong Gubentang Health Industry Development Group Co., Ltd.
7.8.1 Shandong Gubentang Health Industry Development Group Co., Ltd. Company Summary
7.8.2 Shandong Gubentang Health Industry Development Group Co., Ltd. Business Overview
7.8.3 Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Major Product Offerings
7.8.4 Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.8.5 Shandong Gubentang Health Industry Development Group Co., Ltd. Key News & Latest Developments
7.9 Renhe Pharmacy Co., Ltd.
7.9.1 Renhe Pharmacy Co., Ltd. Company Summary
7.9.2 Renhe Pharmacy Co., Ltd. Business Overview
7.9.3 Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Major Product Offerings
7.9.4 Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.9.5 Renhe Pharmacy Co., Ltd. Key News & Latest Developments
7.10 Ningxia Qilixiang Medlar Co., Ltd.
7.10.1 Ningxia Qilixiang Medlar Co., Ltd. Company Summary
7.10.2 Ningxia Qilixiang Medlar Co., Ltd. Business Overview
7.10.3 Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Major Product Offerings
7.10.4 Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.10.5 Ningxia Qilixiang Medlar Co., Ltd. Key News & Latest Developments
7.11 Nu Skin Enterprises
7.11.1 Nu Skin Enterprises Company Summary
7.11.2 Nu Skin Enterprises Business Overview
7.11.3 Nu Skin Enterprises Medicinal and Food Homologous Health Product Major Product Offerings
7.11.4 Nu Skin Enterprises Medicinal and Food Homologous Health Product Sales and Revenue in Global (2018-2023)
7.11.5 Nu Skin Enterprises Key News & Latest Developments
8 Global Medicinal and Food Homologous Health Product Production Capacity, Analysis
8.1 Global Medicinal and Food Homologous Health Product Production Capacity, 2018-2029
8.2 Medicinal and Food Homologous Health Product Production Capacity of Key Manufacturers in Global Market
8.3 Global Medicinal and Food Homologous Health Product Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medicinal and Food Homologous Health Product Supply Chain Analysis
10.1 Medicinal and Food Homologous Health Product Industry Value Chain
10.2 Medicinal and Food Homologous Health Product Upstream Market
10.3 Medicinal and Food Homologous Health Product Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medicinal and Food Homologous Health Product Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer